B cells, MKI67+ T cells and dysfunctional T cells, interact with tumor-associated macrophages (TAMs), which are enriched by preoperative chemotherapy, through HLA-F-LILRB2 and HLA-DPB1-NRG1 pathways in the cell niche of primary tumors. Here, HLA-F is linked to neoplasm.